Thymidine Kinase 2 Deficiency (TK2d)Symptoms, Doctors, Treatments, Advances & More
Thymidine Kinase 2 Deficiency (TK2d) Overview
Learn About Thymidine Kinase 2 Deficiency (TK2d)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
CUIMC/Neurological Institute Of New York
Michio Hirano is a Neurologist practicing medicine in New York, New York. Dr. Hirano is rated as an Elite provider by MediFind in the treatment of Thymidine Kinase 2 Deficiency (TK2d). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Thymidine Kinase 2 Deficiency (TK2d), Mitochondrial Neurogastrointestinal Encephalopathy Disease, MELAS Syndrome, and Progressive External Ophthalmoplegia. Dr. Hirano is currently accepting new patients.
Caterina Garone practices practicing medicine in Bologna, Italy. Ms. Garone is rated as an Elite expert by MediFind in the treatment of Thymidine Kinase 2 Deficiency (TK2d). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Thymidine Kinase 2 Deficiency (TK2d), MELAS Syndrome, Mitochondrial Complex V Deficiency, and Mitochondrial Neurogastrointestinal Encephalopathy Disease.
Cristina Gonzalez-Dominguez practices practicing medicine in Madrid, Spain. Ms. Gonzalez-Dominguez is rated as an Elite expert by MediFind in the treatment of Thymidine Kinase 2 Deficiency (TK2d). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Thymidine Kinase 2 Deficiency (TK2d), Pompe Disease, MELAS Syndrome, and Paramyotonia Congenita.
Summary: The purpose of this clinical trial is to evaluate the efficacy and safety of Doxecitin and Doxribtimine (dC+dT) in adult participants with thymidine kinase 2 (TK2) deficiency attended in the Neuromuscular Unit of '12 de Octubre' Hospital. The main questions it aims to answer are: * Is dT+dC effective in the treatment of the adult participants with TK2 deficiency? * Is dT+dC safe in the treatment o...